2m 2m 2m 2m 2m 2m 2m
BIONXS GENE LAB (BGLC)
NASDAQ
$2.25-$0.03 (-1.32%)
Price as of Jun 03, 2026 7:24 PM EDT- $5.6MMarket Cap
- -30.49%1-Year Change
- Specialty ChemicalsIndustry
BIONXS GENE LAB (BGLC)
$2.25-$0.03 (-1.32%)
BGLC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.28 | ||
Change | -$0.02 (-0.87%) | ||
Open | $2.14 | ||
High | $2.30 | ||
Low | $2.14 | ||
Previous Close | $2.30 | ||
Volume | 2,642 | ||
30-Day Average Volume | 28,196 | ||
1-Week Change | 2.70% | ||
1-Month Change | 9.68% | ||
1-Year Change | -30.49% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 2.4M | ||
Total Assets | $9.0M | ||
Market Cap | $5.6M | ||
Enterprise Value | $4.3M | ||
Period: QTR TTM FY | |||
Revenue | $22,842.00 | ||
Net Income | -$543,575.00 | ||
Free Cash Flow | -$147,996.00 | ||
EBIT | -$543,575.00 | ||
EBITDA | -$515,282.00 | ||
Net Working Capital | $4.4M | ||
EPS | -$0.23 | ||
Enterprise Value/EBITDA | -8 | ||
Enterprise Value/Revenue | 187 | ||
P/B | 1 | ||
P/E | -10 | ||
PEG | N/A | ||
Price/Free Cash Flow | -38 | ||
Price/Operating Cash Flow | -38 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 04/07/2025 | ||
Earnings & Revenue